EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

IMPDH2 dephosphorylation under FGFR signaling promotes S-phase progression and tumor growth

Bei Zhou, Qin Zhao, Guofang Hou, Jing He, Nannan Sha, Ke Zheng, Hongyu Peng, Wang Wang, Yue Zhou, Tao Chen, Yuhui Jiang

Cell Reports · 2025

DOI: 10.1016/j.celrep.2024.115116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Bei Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery and Shanghai Cancer Institute, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, Shanghai Jiao Tong Un…. Hauptthemen laut MEDLINE: IMP Dehydrogenase, S Phase. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Key Technologies Research and Development Program, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IMP DehydrogenaseS PhaseHumansPhosphorylationSignal TransductionCell ProliferationAnimalsMiceCell Line, TumorProtein Phosphatase 2Mice, NudeReceptor, Fibroblast Growth Factor, Type 3HEK293 CellsColorectal Neoplasms

Stichwörter der Autor:innen

CDK1CP: CancerFGFRPP2AS-phase progressionallosteric regulationphosphorylationpurine homeostasistumor cell growth.◼◼◼IMPDH2

Substanzen

IMP DehydrogenaseIMPDH2 protein, humanProtein Phosphatase 2Receptor, Fibroblast Growth Factor, Type 3

Autor:innen und Institutionen

  • Department of Liver Surgery and Shanghai Cancer Institute, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Endoscopy Center, Department of Gastroenterology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Department of Liver Surgery and Shanghai Cancer Institute, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Frontiers Scien…

Förderung

  • National Natural Science Foundation of China
  • Key Technologies Research and Development Program
  • National Key Research and Development Program of China
  • Shanghai Municipal Education Commission

Zitieren

APA

Zhou, B., Zhao, Q., Hou, G., He, J., Sha, N., Zheng, K., Peng, H., Wang, W., Zhou, Y., Chen, T., & Jiang, Y. (2025). IMPDH2 dephosphorylation under FGFR signaling promotes S-phase progression and tumor growth. Cell Reports. https://doi.org/10.1016/j.celrep.2024.115116

Vancouver

Zhou B, Zhao Q, Hou G, He J, Sha N, Zheng K, et al. IMPDH2 dephosphorylation under FGFR signaling promotes S-phase progression and tumor growth. Cell Reports. 2025. doi:10.1016/j.celrep.2024.115116

BibTeX
@article{Zhou2025,
  author = {Zhou, Bei and Zhao, Qin and Hou, Guofang and He, Jing and Sha, Nannan and Zheng, Ke and Peng, Hongyu and Wang, Wang and Zhou, Yue and Chen, Tao and Jiang, Yuhui},
  title = {IMPDH2 dephosphorylation under FGFR signaling promotes S-phase progression and tumor growth},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2024.115116}
}
Kostenlos starten →